Current status: 960 hESC lines, 5441 hiPSC lines, and 132 clinical studies, and 1908 certificates
Monthly statistic from Feb 1, 2024
Posted on February 1, 2024
| total lines | 6401 |
| hESC lines | 960 |
| hiPSC lines | 5441 |
| derivation countries | 46 |
| projects | 288 |
| providers | 879 |
| clinical studies | 132 |
| subclones | 2516 |
| certificates | 1908 |
| cell line certificates | 1764 |
| project certificates | 144 |